BMO Capital raised the firm’s price target on Sherwin-Williams to $386 from $360 and keeps an Outperform rating on the shares. The company’s Q2 earnings beat and guidance raise demonstrated that its investments in 2022-23 are already yielding fruit, and with the housing cycle poised to inflect higher in the next 12 months, along with share gains tied to Sherwin-Williams’ investments and changes in the competitive landscape, the company is poised for earnings beats in the near-term and solid EPS growth over the next few years, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SHW:
- Sherwin-Williams sees Q3 revemue up in low-single digits, consensus $6.36B
- The Sherwin-Williams Company Reports 2024 Second Quarter Financial Results
- Sherwin-Williams raises 204 adj EPS view to $11.10-$11.40 from $10.85-$11.35
- Sherwin-Williams reports Q2 adjusted EPS $3.70, consensus $3.48
- Notable companies reporting before tomorrow’s open